Vimarsana
Biggest News Aggregation in the World

Page 33 - Regulated Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regulated Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regulated Information Today - Breaking & Trending Today

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC - Vimarsana News

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US – April 24, 2023 – 8.00 PM CET Oxurion NV a biopharmaceutical company developing next generation standard of care... | April 24, 2023

Nyrstar NV 2022 Full Year Results | MarketScreener - Vimarsana News

Nyrstar NV 2022 Full Year Results | MarketScreener

Regulated Information Nyrstar NV 2022 Full Year Results 21 April 2022 at 07:00 CEST Nyrstar NV is today announcing the publication of its financial statements for the twelve months ended 31... | April 21, 2023

Tikehau Capital Q1 2023 Announcement - Vimarsana News

Tikehau Capital Q1 2023 Announcement

Continued growth supported by solid fundamentals Regulatory News: During the first quarter of 2023, in an environment marked by persistent macro-economic and geopolitical uncertainties, Tikehau

Committee's decision on Robus Group AS - Vimarsana News

Committee's decision on Robus Group AS

Tallinn, Estonia, 2023-04-19 08:28 CEST -- On April 18, 2023, the Listing and Surveillance Committee of Nasdaq Tallinn decided to impose a fine in the amount of 100 (one hundred) euros to Robus Group

Oxurion NV: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC - Vimarsana News

Oxurion NV: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated Information Leuven, BELGIUM, Boston, MA, US - April 14, 2023 - 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic